It should be noted that examining changes in BDNF and TrkB levels in isolation, whether in preclinical ALS models or in human patients, cannot definitively indicate whether these alterations are adaptive responses to disease or maladaptive responses that contribute to disease etiology. Here, NTRK2 is linked to amyotrophic lateral sclerosis.